ea0014p7 | (1) | ECE2007
Dabrowska Katarzyna
, Stuss Michal
, Gromadzinska Jolanta
, Wasowicz Wojciech
, Sewerynek Ewa
Adriamycin (ADR) is a potent chemotherapeutic agent, effective in treatment of leukemias, lymphomas and of many solid tumours. However, its clinical usage is often limited by cardiotoxicity, induced by oxygen radical damage of membrane lipids.Melatonin (MEL), is a well-known antioxidant. It has been shown that melatonin can scavenge free radicals, both directly or indirectly, stimulating the activity of antioxidative enzyme, e.g., glutathione peroxidase ...